Fresh Evidence Shows Weight Regain After Stopping Anti-Obesity Medications
A recent study conducted by a team from Peking University in China has shed light on how weight can quickly be regained after the cessation of anti-obesity medications (AOMs). Unlike traditional dieting, the researchers focused on the impact of AOMs, which are increasingly being used in weight management programs.
The review included 11 previous studies involving 2,466 individuals who had taken various AOMs, such as glucagon-like peptide-1 receptor agonists (GLP-1 drugs like Ozempic and Wegovy). These medications mimic the natural hormone GLP-1 to regulate appetite and blood sugar levels.
While AOMs were found to be effective in promoting weight loss, the researchers observed a common trend – weight regain following the discontinuation of the drugs. According to lead author Han Wu, significant weight regain occurred as early as eight weeks after stopping AOMs and continued up to 20 weeks post-treatment.
The study highlighted that participants who lost more weight during the treatment phase also tended to regain more weight once the AOMs were discontinued. This pattern was particularly evident in individuals who had taken GLP-1 drugs.
Further analysis considered various factors that could influence weight loss, such as physical activity levels and the presence of diabetes. However, the exact mechanisms behind this weight regain phenomenon remain unclear.
Previous research, including a study on tirzepatide (Zepbound), showed that participants who switched from AOMs to a placebo experienced a significant portion of lost weight returning. This trend is not unique to AOMs and has been observed in other weight management approaches like gastric bypass surgeries.
While AOMs offer promising results in weight reduction, the study underscores the importance of long-term monitoring and support for individuals post-treatment. Researchers advocate for larger, extended studies to investigate strategies for maintaining weight loss after discontinuing AOMs or explore alternative, healthier interventions.
The findings of this study have been published in BMC Medicine, urging the scientific community to delve deeper into the complexities of weight management and the implications of AOM use.
